News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zeria Pharmaceutical Co., Ltd. Licenses Gastric Ulcer Drug To SK Chemicals Co. Ltd.



3/3/2006 10:58:37 AM

Tokyo, Mar 2, 2006 (JCN) - ZERIA Pharmaceutical announced on March 2 that it had concluded a licensing agreement with Korean company SK Chemicals as of February 27. Under the terms of the agreement, SK Chemicals is licensed to develop and sell Promac Granules 15%, ZERIA's proprietary ethical agent for the treatment of gastric ulcers, exclusively in Korea.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES